With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...

Scientists may have discovered a way to naturally regulate blood sugar levels and sugar cravings that works similarly to ...

Novo Nordisk stock surged Friday after the obesity kingpin reported strong results for its next-generation weight-loss drug, amycretin.

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called GLP-1.

For decades, the United States has held considerable power in determining the direction of global health policies and programs.